NDC 70518-0714

PREZCOBIX

Darunavir Ethanolate And Cobicistat

PREZCOBIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Darunavir Ethanolate; Cobicistat.

Product ID70518-0714_75b2e380-4617-96f5-e053-2991aa0ae9cc
NDC70518-0714
Product TypeHuman Prescription Drug
Proprietary NamePREZCOBIX
Generic NameDarunavir Ethanolate And Cobicistat
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2017-08-28
Marketing CategoryNDA / NDA
Application NumberNDA205395
Labeler NameREMEDYREPACK INC.
Substance NameDARUNAVIR ETHANOLATE; COBICISTAT
Active Ingredient Strength800 mg/1; mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70518-0714-0

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0714-0)
Marketing Start Date2017-08-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0714-0 [70518071400]

PREZCOBIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205395
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-28
Marketing End Date2020-05-04

Drug Details

Active Ingredients

IngredientStrength
DARUNAVIR ETHANOLATE800 mg/1

OpenFDA Data

SPL SET ID:e4867e5d-aa52-4f6b-a998-a90203b3853e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1600704
  • 1600710
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • P-Glycoprotein Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]

    NDC Crossover Matching brand name "PREZCOBIX" or generic name "Darunavir Ethanolate And Cobicistat"

    NDCBrand NameGeneric Name
    50090-1723PREZCOBIXDARUNAVIR ETHANOLATE and COBICISTAT
    59676-575PREZCOBIXDARUNAVIR ETHANOLATE and COBICISTAT
    70518-0714PREZCOBIXDARUNAVIR ETHANOLATE and COBICISTAT

    Trademark Results [PREZCOBIX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PREZCOBIX
    PREZCOBIX
    85845782 4720657 Live/Registered
    JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
    2013-02-11

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.